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a b s t r a c t
Objective: To analyse the evidence concerning the accuracy of the Mini-Mental State Examination (MMSE) as a
diagnostic and screening test for the presence of delirium in adults.
Method: Two authors searched MEDLINE, PsychINFO and EMBASE from inception till March 2014. Articles were
included that investigated the diagnostic validity of the MMSE to detect delirium against standardised criteria. A
diagnostic validity meta-analysis was conducted.
Results: Thirteen studies were included representing 2017 patients in medical settings of whom 29.4% had delirium.
The meta-analysis revealed the MMSE had an overall sensitivity and speciﬁcity estimate of 84.1% and 73.0%, but
this was 81.1% and 82.8% in a subgroup analysis involving robust high quality studies. Sensitivity was unchanged
but speciﬁcity was 68.4% (95% CI=50.9–83.5%) in studies using a predeﬁned cutoff of b 24 to signify a case. In
high-risk samples where delirium was present in 25% of patients, then the Positive predictive value and Negative
predictive value would be 50.9% (48.3–66.2%) and 93.2% (90.0–96.5%).
Conclusion: The MMSE cannot be recommended as a case-ﬁnding conﬁrmatory test of delirium, but may be used as
an initial screen to rule out high scorers who are unlikely to have delirium with approximately 93% accuracy.
© 2014 Elsevier Inc. All rights reserved.

1. Introduction
Delirium is a common and pervasive neuropsychiatric condition [1]
and the term has been used for acute confusion in the International
Classiﬁcation of Diseases, 10th Revision (ICD-10) [2]and the Diagnostic
and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) [3]. A
number of features deﬁning delirium include rapid onset of symptoms
that tend to ﬂuctuate even during the same day with an altered level of
consciousness, global disturbance of cognition or perceptual abnormalities with evidence of a physical cause, substance intoxication/withdrawal
or multiple etiologies. The presence of delirium causes great concern since
people affected have worse outcomes including longer hospital stays,[4,5]
high risk of dementia,[6]higher rate of hospital-acquired complications,
such as, falls and pressure sores[7,8] and increased mortality [9–11].
In addition, delirium complicates between 17–61% of major surgical
procedures [12].
Many older adults are affected by delirium, for instance up to 50%
of hospitalized patients can be diagnosed with delirium [13]. The
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prevalence of delirium on medical wards in hospital is about 3% to 30%
[14,15] whilst it other research has demonstrated it may affect between
11–42% of general medical inpatients [13]. Delirium is also problematic
at end of life care and may affect up to 83% of older adults [12]. Within
the literature, there is a large variation in reporting incidence and prevalence rates of delirium [16–19]. There are numerous reasons that may
account for this variability in rates including the source of sample, nature
and variety of symptoms, diagnostic criteria and methods used.
Delirium risk is higher in palliative care, intensive care and in
patients undergoing cardiothoracic surgery, emergency orthopedic procedures (repair of a hip fracture), vascular surgery or cataract removal
[20,21]. Despite the pronounced prevalence and impact of delirium,
healthcare professionals ability recognize it is poor with around 50% of
cases of delirium going unrecognized [12,22,23]. This is exempliﬁed in
one recent study where emergency physicians missed delirium in 76%
of cases [24]. In another study in an intensive care unit, nurses' detection
sensitivity was 27% and speciﬁcity 92%, compared with the Confusion
Assessment Method (CAM) for the intensive care unit (ICU) [25]. The
fact that delirium is common, troublesome but under-recognized,
suggests a role for screening instruments [26,27].
In recognition of this, recent guidelines (NICE, 2010) [28] stipulate
that all elderly people admitted to hospital or in long-term care units
should be screened for risk factors of developing delirium and cognitive
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impairment, using a brief cognitive test. Recently, several reviews of
screening instruments to detect delirium have been published. A recent
review of 11 instruments in 25 studies highlighted potentially
favourable accuracy for Global Attentiveness Rating, Memorial Delirium
Assessment Scale (MDAS), Delirium Rating Scale-Revised-98 (DRS-R-98),
Clinical Assessment of Confusion, Delirium Observation Screening Scale
and Nursing Delirium Screening Scale. The CAM was the most thoroughly
investigated but notable the Mini-Mental State Examination (MMSE)
was partially omitted from this review. Although the MMSE is designed
to assess global cognitive impairment, and it currently under licence
(pay per use), it may prove potentially useful to detect delirium and
is already commonly used in a range of clinical settings. Many studies
have looked at the diagnostic value of the MMSE in cognitive disorders
but mostly in context of dementia, not delirium [29]. The MMSE has
been used extensively in different clinical and non-clinical settings [30].
It is a brief test consisting of 20 individual tests covering 11 domains
including orientation, registration, attention and calculation, recall,
naming, repetition, comprehension, writing and construction. Many
validation studies exist, but most are underpowered and many lack an
adequate criterion standard and hence can give a misleading impression
of accuracy [31]. The MMSE is a valid test of cognitive functions and is
reliable for 24-h and 28-day assessment for single or multiple raters
(Pearson Coefﬁcient 0.877). Internal consistency appears to be moderate
with Cronbach alpha scores ranging from 0.6 to 0.89 [32,33]. However, its
utility in detecting delirium is uncertain although a large study regarding
the MMSE and delirium found a mean MMSE score of 12.6 in those with
delirium and 25.7 in those without [34]. Despite the fact the MMSE is
widely used to screen for cognitive impairment, its value in diagnosing
delirium is uncertain and requires investigation. Thus, the aim of this
paper was to systematically review and analyze the evidence concerning
the accuracy of the MMSE as a diagnostic (case-ﬁnding) and screening
test for the presence of delirium in adults.

2. Methods
This systematic review and meta-analysis was conducted in
accordance with the PRISMA guidelines following a predetermined
protocol [35].

2.3. Methodological quality appraisal
2.3.1. Quality assessment and risk of bias assessment
Two authors (B.S., A.J.M.) conducted the risk of bias assessment using
a four point quality rating and a ﬁve point bias risk was applied to each
study as used in a recent similar study [36]. The quality rating score
was based on study sample size, study design, study attrition and method of dealing with possible confounders with the following scale: 1=low
quality 2=low–medium quality 3=medium–high quality 4=high quality. The bias rating score evaluated possible bias in assessments of results
as inﬂuenced by consideration of setting, sampling method, interview
method and sampling method. Bias was rated with the following score:
0=no appreciable bias risk 1=low bias risk 2=low–medium bias risk
3=medium–high bias risk 4=high bias risk. A composite score of N 3
on study quality+b3 on bias score generated seven robust studies.
2.3.1.1. Analysis. An unweighted pooled meta-analysis of suitable studies
was conducted, to give overall test accuracy, sensitivity, speciﬁcity, combined Youden score, positive and negative predictive values (PPV, NPV),
positive and negative likelihood ratios (LR+, LR−) and positive and negative clinical utility index (CUI+, CUI −). Further details are available
here www.clinicalutility.co.uk. The CUI is a proxy for the applied value
of a test with a qualitative as well as quantitative interpretation [37–39].
Clinical utility may be more important to clinicians than validity [40]. Clinical utility estimates the clinical value of a diagnostic test taking into account both the accuracy of the test and its occurrence. The positive
utility index (for rule-in or case-ﬁnding accuracy) is a product of
sensitivity and positive predictive value and the negative utility index
(for rule-out or screening accuracy) is a product of Sp × NPV. The interpretation of the CUI is 0.93–1.00 near perfect value; 0.81–0.92
excellent; 0.64–0.80 good; 0.49–0.63 adequate; 0.36–0.48 poor; and
b 0.36 very poor. Publication bias was tested by Harbord method [41].
Comparative accuracy was tested by conducting a relative risk comparison of pooled sensitivity and speciﬁcity and by comparing overall accuracy at equivalent prevalence rates of 25% and 50%. In order to assess the
inﬂuence of the quality of studies on the observed results, we conducted
subgroup analysis using most robust (high quality) studies only where
the delirium was determined by robust interview methods. As the included studies used a variety of cutoff thresholds we also conducted a
subgroup analysis to establish the observed results differed in studies
using a predeﬁned cutoff of b 24 on the MMSE.

2.1. Data sources and search
3. Results
Two independent reviewers searched Medline, PsycINFO and
Embase abstract databases from inception to March 2014. This was
supplemented by searches of ﬁve full text collections (Science Direct,
Ingenta Select, Ovid Full Text, Blackwell Online and Wiley Interscience)
and the abstract database Web of Knowledge (4.0, ISI). In accordance
with the protocol, where necessary, authors were contacted directly
for primary data. The following search terms were used: “(Screen* or
test or instrument or measure or tool or diagnos*) and (Mini mental
state examination or MMSE or Folstein) and (delirium or cogniti*) and
(“sensitivity and speciﬁcity or accuracy or cutoff or receiver operator
or ROC or Youden”).

2.2. Eligibility criteria
We included studies that examined the diagnostic validity of the
MMSE to detect delirium against the reference standard according to
the DSM-IV of the American Psychiatric Association (for example
DSM-IV) or ICD (for example ICD-10) of the World Health Organization
criteria. Studies that did not clearly state the comparator to be DSM or
ICD diagnosis for delirium, or that did not provide sufﬁcient data to be
extracted and included in the meta-analysis were excluded. We did
not place a language restriction upon eligible studies.

3.1. Part 1 systematic review
We identiﬁed 13 valid studies of the MMSE for the detection of
delirium in medical settings involving a total of 2017 patients of
whom 29.4% had delirium [42–54]. Studies were published between
1982 and 2011. The smallest study involved 18 cases of delirium [43]
whilst the largest had 142 cases [50]. The prevalence of delirium ranged
from 11.7% to 58.3%. All of the studies had acceptable methodological
quality and none of the studies were deemed to be at high risk of bias.
A full summary of the included articles details including methodological
quality and risk of bias is shown in Table 1.
Anthony et al. studied 97 patients, who were admitted consecutively
to a General medical ward at John Hopkins Hospital in 1979, aged above
20 years [42]. The sample was predominantly female, black, with little
education and from a socioeconomically deprived background. DSM
criteria were used as the gold standard, applied by a trained psychiatrist.
The MMSE was administered within 24 h of admission to the ward. At a
cutoff of b 24, the MMSE had a sensitivity of 87.0% and a speciﬁcity of
82.4% in diagnosing delirium or dementia. This study was atypical in
that delirium or dementia. Was the gold standard. The authors also
calculated sensitivity and speciﬁcity at various cutoff points on the
MMSE. Trzepacz et al. examined 108 liver transplantation candidates

DSM-IV-TR by psychiatrists
DSM-III Delirium
Sharma et al. (2011)*
Trzepacz et al. (1988)

CDT, clock drawing test; Quality rating scores 1=low quality 2=low-medium quality 3=medium–high quality 4=high quality. Bias rating scores 0=no appreciable bias risk 1=low bias risk 2=low to medium bias risk 3=medium to high bias risk
4=high bias risk. *High quality studies used in subgroup analysis.

87 males 62 females
35% male
44 years
41 years
2
3
3
2
149
108
N18 years
108 consecutive liver
transplant candidates

DSM-III-R Delirium by Psychiatrists
DSM-III-R Delirium by Psychiatrists
Rockwood et al. (1996)*
Rolfson et al. (1999)

DRS
CAM, CDT

CAM
CAM
O'Keeffe et al. (2005)*
Ringdal et al. (2011)*

none
Trails A, B; EEG

104
71

3
3

2
3

79 years
71 years

NR
80% male,

Hospital
Hospital patients with
hip fracture
Hospital
Hospital inpatients
undergoing cardiac
surgery
Hospital
Hospital
NR
76% female
79 years
Over 65 years
2
2
3
3
160
364

79 years
84 years, 76% female,
54% with MMSEb24
79 years
80% male, mean age
71 years

65–89 years
2
3
100
65–89 year

CAM
DSI
none
none
ICD-10-DCR Delirium
Khurana et al. (2002)*

Brief 4 items MMSE
None
CAM), the DRS, the MDAS
Cognitive test for delirium
ICD-10 Delirium
Two step: CAM-S then DRS-R98
DSM-III-R Delirium
DSM-III-R Delirium by Psychiatrists

Dyer et al. (1994)

Fayers et al. (2005)*
Franco et al. (2010)
Grassi et al. (2001)*
Hart et al. (1996)

DSI

64% males 36% females

Hospital
Hospital
Hospital
Hospital (controls
included outpatients)
Hospital
42% male
186 females and 105 males
55 males
42.5% female
80 years
74.4 years
67.7 years
62.5years
1
2
2
2
4
2
3
2
305
291
105
103

Hospital
97% male,
70.1 years
3
2
60

Hospital
37 male, 60 female
60 years
3
3
97

97 patients (37 male)
46 over 60 years
97% male, mean age
70.1 years
80 years, 58% female
60–99 years
55 males 67.7 years
NR
Delirium OR Dementia
DSM-III by Psychiatrist
CAM
Anthony et al. (1982)

none

Diagnosis of delirium
Study author (year)

Table 1
Methodological Summary of studies.

Comparisons

Sample, age, gender

Total study size

Quality rating score

Bias rating score

Mean age

Gender

Setting
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with end-stage liver disease from gastroenterology service at
Presbyterian-University Hospital, Pittsburgh, PA, USA [43]. They were
all English speaking, with 11 or more years of education. Subjects
were between 17 and 62 years of age. Psychiatric diagnoses were
made using DSM-III criteria. A MMSE score of less than 24 had a sensitivity of 55.6% and a speciﬁcity of 82.2% in detecting delirium. Further PPV
was 38.5% and NPV 90.2%. Comparatively the trail making test B had
66.7% sensitivity and 95.6% speciﬁcity.
Dyer et al. conducted a prospective study on the diagnosis postoperative delirium comparing the 107 item Delirium Symptom Interview
(DSI) and the MMSE to the CAM [44]. The CAM developed in 1990 was
used as the gold standard [55]. The subjects were 60 consecutive patients
who underwent general, orthopaedic or urologic surgery. DSI, MMSE and
CAM were administered pre-operatively and post-operatively (days
1–7); 12% of subjects had a pre-operative diagnosis of dementia or
depression and 58% developed delirium. The MMSE had 77.1% sensitivity,
56.0% speciﬁcity 71.1% PPV and 63.6% NPV. Comparatively the DSI
had 92% sensitivity and 64% speciﬁcity. Hart et al. set out to validate
two forms of Cognitive Test for Delirium (CTD) in medical ICU patients
[45]. They also compared the performance of CTD to the MMSE and investigated whether these tests can be used to differentiate delirium from
other mental illnesses such as dementia in out-patient setting, depression
and schizophrenia in in-patient psychiatry service in the Medical College
of Virginia. There were less than 30 patients in each group. The DSM-III-R
was used as the gold standard for diagnosis. An receiver operating characteristic (ROC) analysis indicated that for both CTD and the MMSE, an
optimal cutoff score to discriminate delirium from other disorders was
b19. At this score, the MMSE had a sensitivity of 100% and speciﬁcity of
93.8%. Rockwood et al. compared the MMSE with the DRS in a crosssectional study in 1992 in Ontario, Canada [46]; 104 inpatients from
geriatric medicine and geriatric psychiatry wards of two tertiary referral
hospitals participated in the study. DSM-III-R was used as the gold
standard for diagnosis of delirium. The subjects were administered the
Delirium Rating Scale (DRS), MMSE, Barthel Index and Blessed Dementia
Scale.. At a cutoff of b 24, MMSE showed a sensitivity of 88.5% and
speciﬁcity of 52.6%. Comparatively the DRS had 82% sensitivity and 94%
speciﬁcity when 10 is set as the cut-point. Rolfson et al. studied a cohort
of 71 consecutive patients undergoing elective coronary artery bypass
graft at a tertiary care hospital in Northern Alberta, Canada [47]. The
primary objective was to assess the validity of the CAM to detect delirium
but the authors also included data on the MMSE. Patients were followed
daily until the fourth postoperative day. Delirium was diagnosed using
the DSM-III-R criteria. The ROC curves were constructed for the CAM
and MMSE. At a cutoff of b24, the MMSE had a sensitivity of 34.8% and
a speciﬁcity of 81.3%. Comparatively the CAM had 70% sensitivity and
100% speciﬁcity.
Seven studies have been published since 2000. In Grassi et al.
conducted a study which was carried out in 6 centres in Italy, including
4 medical oncology wards and 2 palliative care units [48]; 105 consecutive cancer inpatients presenting with a mental status change that were
referred to the consultation-liaison psychiatric service or palliative care
unit were evaluated. The objective was to validate the Italian versions of
the DRS and the MDAS. The criterion reference was DSM-III-R criteria for
delirium. Using a cutoff of b24, the MMSE showed a sensitivity of 95.5%
and a speciﬁcity of 38.5%, PPV of 72.4% and NPV of 83.3%. Comparatively
the MDAS had 68% sensitivity and 94% speciﬁcity for a cutoff of 13 for
delirium. The DRS had 95% sensitivity and 61% speciﬁcity for DRS cutoff
10 and 81% sensitivity and 76% speciﬁcity for DRS cutoff 12. Khurana
et al. studied 100 hospitalised geriatric general medical patients, aged
65 and above, who were admitted under the Department of Internal
Medicine, Kasturba Hospital, Manipal, Karnataka [49]. The patients
were assessed within 24 h or admission 61 and then on every fourth
day thereafter. The assessment was carried out using the MMSE, CAM,
DSI against the ICD-10 criteria for delirium. At a cutoff score of b24,
the MMSE showed 100% sensitivity and 45.2% speciﬁcity. In comparison, the CAM had 100% sensitivity and 100% speciﬁcity. Also, the DSI

0.527 (0.503–0.551) “fair”
0.548 (0.530–0.566) “fair”
0.894 (0.893–0.896) “good”
0.141 (0.133–0.149) “v poor”
0.691 (0.685–0.698) “good”
0.815 (0.801–0.828) “excellent”
0.403 (0.387–0.419) “poor”
0.666 (0.653–0.679) “good”
0.297 (0.291–0.302) “v poor”
0.339 (0.322–0.357) “v poor”
0.164 (0.131–0.197) “v poor”
0.383 (0.368–0.398) “poor”
0.214 (0.181–0.246) “v poor”
0.16 (0.05–0.46)
0.41 (0.20–0.82)
0.11 (0.07–0.17)
0.47 (0.28–0.80)
0.12 (0.04–0.38)
NA
NA
0.09 (0.03–0.27)
0.22 (0.12–0.41)
0.22 (0.07–0.65)
0.80 (0.58–1.11)
0.27 (0.14–0.53)
0.54 (0.32–0.91)
4.95 (2.95–8.31)
1.75 (1.09–2.83)
NA
1.89 (1.44–2.47)
1.55 (1.20–2.00)
16.2 (6.93–37.9)
1.83 (1.48–2.25)
9.17 (5.36–15.7)
1.92 (1.66–2.24)
1.86 (1.42–2.45)
1.86 (0.82–4.18)
2.84 (2.04–3.97)
3.13 (1.70–5.73)
0.953 (0.901–1.00)
0.636 (0.435–0.837)
0.916 (0.875–0.957)
0.942 (0.906–0.877)
0.833 (0.661–1.00)
1.00 (1.00–1.00)
1.00 (1.00–1.00)
0.974 (0.945–1.00)
0.945 (0.911–0.980)
0.932 (0.857–1.00)
0.722 (0.603–0.842)
0.921 (0.864–0.977)
0.902 (0.838–0.967)
0.606 (0.439–0.773)
0.711 (0.566–0.855)
1.00 (1.00–1.00)
0.20 (0.128–0.272)
0.724 (0.630–0.818)
0.815 (0.668–0.961)
0.403 (0.286–0.520)
0.727 (0.597–0.856)
0.337 (0.271–0.402)
0.383 (0.260–0.506)
0.471 (0.233–0.708)
0.475 (0.350–0.601)
0.385 (0.198–0.572)
0.824 (0.738–0.911)
0.56 (0.365–0.755)
1.00 (1.00–1.00)
0.626 (0.567–0.686)
0.385 (0.235–0.537)
0.938 (0.886–0.991)
0.452 (0.338–0.566)
0.900 (0.847–0.953)
0.542 (0.484–0.599)
0.526 (0.415–0.636)
0.813 (0.702–0.923)
0.717 (0.635–0.800)
0.822 (0.743–0.901)
0.870 (0.732–1.00)
0.771 (0.632–0.911)
0.894 (0.844–0.945)
0.706 (0.553–0.859
0.955 (0.904–0.100)
1.00 (1.00–1.00)
1.00 (1.00–1.00)
0.917 (0.826–1.00)
0.882 (0.809–0.954)
0.885 (0.762–1.00)
0.348 (0.153–0.542)
0.806 (0.676–0.935)
0.556 (0.326–0.785)

Footnote: values calculated from raw data using www.clinicalutility.co.uk calculator. The CUI is a proxy for the applied value of a test with a qualitative as well as quantitative interpretation: CUI+ve for case ﬁnding and CUI−ve for screening.
+ve, positive; −ve, negative.

3.2.1.1. Main analysis. Examining sensitivity and speciﬁcity, we found a
diagnostic validity meta-analysis gave an overall sensitivity estimate
of 84.1% (95% CI=75.8–90.9%). It was no different in studies using a
predeﬁned cutoff of b 24. Regarding speciﬁcity meta-analysis gave an

23v24
NR
23v24
b24
23v24
18v19
b24
Fall of 2 points
23v24
23v24
23v24
b24.5
NR

3.2.1. Sensitivity and speciﬁcity

Anthony et al. (1982)
Dyer et al. (1994)
Fayers et al. (2005)
Franco et al. (2010)
Grassi et al. (2001)
Hart et al. (1996)
Khurana et al. (2002)
O'Keeffe et al. (2005)
Ringdal et al. (2011)
Rockwood et al. (1996)
Rolfson et al. (1999)
Sharma et al. (2011)
Trzepacz et al. (1988)

We located 13 studies, all in hospital settings. The total sample size
was 2017 of whom 564 giving a pooled prevalence of delirium of
27.9% (25.9–29.9%); corrected to 29.4% (95% CI=21.5–37.9%) on metaanalysis. However, this was 31.6% (95% CI=21.6–42.6%) in robust
(high quality) studies using interview based criteria. The statistical summary of the individual results from each study are presented in Table 2.

Table 2
Statistical Summary of studies.

3.2. Part 2: meta-analytic results

Cutoff

Sensitivity (95% CI) Speciﬁcity (95% CI)

PPV (95% CI)

NPV (95% CI)

Likelihood ratio+ve Likelihood ratio+ve CUI+ve
(95% CI)
(95% CI)

CUI−ve

had 100% sensitivity and 90% speciﬁcity. Fayers et al. recruited 150
patients, diagnosed with delirium, between the ages of 70 and 90,
from a general medical unit for somatic diseases in a University Hospital, Norway [50]. Trained nurses administered the MMSE. The
authors also studied a separate group of 163 consecutive patients who
were admitted at the same hospital and of similar age but with no
diagnosis of delirium or other cognitive impairment. At a cutoff of
b 24, the MMSE had a sensitivity of 89.4% and speciﬁcity of 100% in
this sample with 100% PPV and 91.6% NPV. O'Keeffe et al. looked at
the value of serial MMSEs in diagnosing and monitoring delirium in
Ireland [51]. In this prospective study 165 consecutive patients aged
65 and older who were admitted from the accident and emergency
department to an acute geriatric medicine service were recruited. Two
different examiners blind to each other, administered the MMSE to
the subjects on Days 1 and 6. On the same hospital days, an experienced
consultant geriatrician examined the subjects and diagnosed delirium
using the CAM diagnostic algorithm. A fall of two or more points on
the MMSE was the best determinant for detecting the development of
delirium. This change score yielded a sensitivity of 91.7% and speciﬁcity
of 90.0%. A rise of 3 or more points was the best determinant for detecting resolution of delirium with a sensitivity of 77% and speciﬁcity of 75%.
Since 2010 a further three studies have been published. Sharma et al.
studied 149 consecutive patients who had been referred to the psychiatric
department for behavioural abnormalities from various other departments in Shree Krishna hospital, Karamsad, Gujarat, over 1 year. The
aim of the study was to assess the optimal cutoff for MMSE to detect
delirium, using DSM-IV-TR as the gold standard. Diagnoses were made
by a psychiatrist blind to the MMSE score. Using the ROC analysis, the
optimal cutoff score of the MMSE was 24.5, giving a sensitivity of 97%
and a speciﬁcity of 69% but at b 24 sensitivity was 80.6% and speciﬁcity
71.8%. Franco et al. examined 291 patients aged over 60 who were
hospitalised in three internal medicine wards in Clinica Universitaria
Bolivariana, Columbia. The patients were assessed within 24 h of admission using CAM-Spanish (CAM-S) then DRS-R-98 (two-step procedure).
Those who scored ‘positive’ were excluded and ‘negative’ were evaluated
using the Colombian version of the MMSE, to measure global cognitive
status. Using the cutoff score for the MMSE b 24.5, a sensitivity of 79.4%
and a speciﬁcity of 52.1% was found but at b 24 sensitivity was 70.6%
and speciﬁcity 62.6%. The positive and negative predicted values were
20.0% and 94.2%, respectively. However, a limitation of this paper is
that the criterion reference was two-step procedure and an important
consideration is that the authors appear to measure the incidence and
not the prevalence of delirium. Ringdal et al. examined the value of the
MMSE for detecting delirium in 364 over 65-year-old Norwegianspeaking subjects [52]. This was the largest study in the literature.
Some MMSE questions were modiﬁed into Norwegian. The CAM was
used as the gold standard with b 24 as the cutoff point. The MMSE had
a sensitivity of 88.2% and a speciﬁcity of 54.2% in detecting delirium
(PPV was 33.7% and NPV 94.5%). A summary of the included studies is
presented in Table 1.

0.786 (0.780–0.791) “good”
0.356 (0.324–0.388) “v poor”
0.916 (0.915–0.917) “excellent”
0.590 (0.587–0.593) “fair”
0.321 (0.294–0.347) “v poor”
0.938 (0.937–0.940) “excellent”
0.452 (0.438–0.466) “poor”
0.876 (0.875–0.878) “excellent”
0.512 (0.509–0.515) “fair”
0.490 (0.478–0.501) “poor”
0.587 (0.575–0.599) “fair”
0.660 (0.654–0.665) “good”
0.742 (0.737–0.747) “good”
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Fig. 1. Bayesian Conditional Probability Plot of MMSE Accuracy. Footnote: The Bayesian Conditional Probability Plot shows the positive and negative predictive values for every possible
prevalence value. HQ=high quality studies; All=all studies.

overall sensitivity estimate of 73.0% (95% CI=59.6–84.5%) (Fig. 1). It
was 68.4% (95% CI=50.9–83.5%) in studies using a predeﬁned cutoff
of b24.
3.2.1.2. Sub-analysis (high-quality studies). Sub-analysis including only
robust (high quality) studies using interview-based criteria for
delirium was conducted. Seven such studies had a meta-analytic
sensitivity of 81.1% (95% CI=65.9–92.6%) and a speciﬁcity of 82.8%
(95% CI=64.4–95.4%).

Assuming delirium was present in 25% of patients, then the positive
clinical utility would be 0.428 (qualitatively poor) and the negative
clinical utility would be 0.681 (qualitatively good).
If the MMSE was used in a modest risk setting (prevalence 10%) then
it would likely facilitate in the correct detection of 8 delirious patients,
missing 2, and correctly ruling out 66 non-delirious patients falsely suggesting 24. If the MMSE was used in a high risk setting (prevalence 25%)
then it would likely facilitate in the correct detection of 21 delirious
patients, missing 4, and correctly ruling out 55 non-delirious patients
but with 20 false positives.

3.2.2. Positive and negative predictive value
3.2.2.1. Main analysis. Using the main analysis for sensitivity and speciﬁcity, and assuming delirium was present in 10% of patients, then the
PPV and NPV would be 25.7% (17.3–39.5%) and 97.6% (95.7–98.8%), respectively, with a positive likelihood ratio of 3.11 (1.88–5.86) and
negative likelihood ratio of 0.22 (0.41–0.11) (Fig. 1). Assuming delirium
was present in 25% of high-risk patients, then the PPV and NPV would
be 50.9% (48.3–66.2%) and 93.2% (90.0–96.5%), respectively, with the
same likelihood ratios.
3.2.2.2. Sub-analysis (high quality studies). Using the high quality subanalysis conﬁned to 7 robust (high quality) studies then sensitivity
and speciﬁcity, and assuming delirium was present in 10% of patients,
then the PPV and NPV would be 34.4% (17.1–69.1%) and 97.5%
(94.4–99.1%), respectively with a positive likelihood ratio of 4.72
(1.85–20.1) and negative likelihood ratio of 0.23 (0.08–0.53). Assuming
delirium was present in 25% of high-risk patients, then the PPV and NPV
would be 61.1% (38.2–87.0%) and 92.9% (85.0–97.5%), respectively,
with the same likelihood ratios.
3.2.3. Clinical utility
3.2.3.1. Main analysis. Assuming delirium was present in 10% of patients,
then the positive clinical utility would be 0.216 (qualitatively poor)
and the negative clinical utility would be 0.713 (qualitatively good).

3.2.3.2. Sub-analysis (high quality studies). Using the robust (high quality)
sub-analysis conﬁned to 7 studies, and assuming delirium was present in
10% of patients, then the positive clinical utility would be 0.279 (qualitatively poor) and the negative clinical utility would be 0.808 (qualitatively
good). Assuming delirium was present in 25% of patients, then the positive clinical utility would be 0.496 (qualitatively poor) and the negative
clinical utility would be 0.769 (qualitatively good).
If the MMSE was used in a modest risk setting (prevalence 10%) then
it would likely facilitate in the correct detection of 8 delirious patients,
missing 2, and correctly ruling out 75 non-delirious patients falsely suggesting 15. If the MMSE was used in a high risk setting (prevalence 25%)
then it would likely facilitate in the correct detection of 20 delirious
patients, missing 5, and correctly ruling out 62 non-delirious patients
but with 13 false positives.
4. Discussion
We located 13 valid diagnostic studies of the MMSE involving 2017
individuals tested for delirium. An inclusive approach (including all
qualifying studies) led to a sensitivity and speciﬁcity estimate for the
MMSE of 84.1% (95% CI=75.8–90.9%) and 73.0% (95% CI=
59.6–84.5%). However, only 7 studies were of deemed to be highest
quality and used interview based criteria for delirium. In addition, one
study used a two-step procedure of the CAM in order to ﬁnd incident
delirium cases during hospitalization, that were then quantiﬁed with

632

A.J. Mitchell et al. / General Hospital Psychiatry 36 (2014) 627–633

the DRS-R98 [54]. and this may have inﬂuenced the pooled metaanalysis results. Another included patients with delirium and/or dementia (although the remainder excluded dementia) [42].
Therefore, excluding these and other lower quality studies led to a
best estimate of sensitivity and speciﬁcity reﬁned to 81.1% (95% CI=
65.9% to 92.6%) and 82.8% (95% CI=64.4% to 95.4%), respectively. Taking
this high quality study estimate, in both medium risk and high-risk settings the clinical utility of the MMSE was qualitatively poor for caseﬁnding. However, in both medium risk and high-risk settings the clinical
utility of the MMSE was qualitatively good for screening. For example
when the prevalence of delirium was 10% the MMSE achieved 97.5%
NPV. If the MMSE was used in a modest risk setting (prevalence 10%)
as an initial screening tool then it would likely facilitate in the correct detection of 8 out of 10 delirious patients, missing 2. If the MMSE was used
in a high risk setting (prevalence 25%) then it would likely facilitate in
the correct detection of 20 delirious patients, missing about 5 cases.
The MMSE is the most widely used test of cognitive impairment but
its role in assessing delirium has never been adequately clariﬁed. The
MMSE was designed to assess broad cognitive impairment whereas
other tools have been speciﬁcally designed for screening (e.g., CAM
and DSI) or ascertaining the severity of delirium (e.g. DI, MDAS and
DRS-R-98) [56]. Nevertheless, the MMSE is the most popular tool in
clinical practice and the one most often used by clinicians to screen for
delirium. Clinicians may, however, assume the MMSE is both an
adequate screening and case-ﬁnding tool. Few studies have offered a
head-to-head comparison of focussed delirium screens against the
MMSE. Assuming replication from at least one independent centre is
necessary in order to make a judgement about such a comparison we
could only ﬁnd a comparison with the DRS (two studies)[46,48] and
the confusion assessment method (CAM) (2 studies) [49,51].
Against the DRS the MMSE had inferior sensitivity and inferior
speciﬁcity in both studies (DRS SE: 90% Sp 82% vs MMSE SE: 88.5% Sp
52.6%)[48] (DRS SE: 80% Sp 76% vs MMSE SE 66% Sp 38.5%)[50]. Against
the CAM the MMSE appeared to have equal or inferior sensitivity and
inferior speciﬁcity in both studies (CAM SE: 100% Sp 100% vs MMSE
SE: 100% SP 45.2%)[51] (CAM SE: 70% Sp 100% vs MMSE SE: 35% SP
81.3%) [49]. Although the sample size is low we can state that the
MMSE is probably less accurate that its competitors (CAM and DRS)
when diagnosing delirium. However, it is important to note that the
differential effect upon missed negatives is very small using either
CAM or DRS vs. MMSE. In other words for screening purposes the
MMSE is probably acceptable but for case-ﬁnding, competitor tools
are preferred. Future studies may clarify if speciﬁc domains of the
MMSE can be used in isolation, for example orientation or spelling. In
addition it is likely that accuracy can improved by serial testing [51].
The under-recognition of delirium can be associated with factors such
as the ﬂuctuating nature of delirium, its overlap with dementia and depression, the scarcity of formal cognitive assessment in general hospitals
by routine, under-appreciation of its clinical consequences, and failure to
consider the diagnostic importance. Non-detection of delirium has been
also associated with the high prevalence of the hypoactive form of delirium. Four independent risk factors for the under-recognition of delirium
by nurses have been identiﬁed: hypoactive delirium, advanced age, visual impairment and dementia [57]. It should also be remembered that
subtypes of delirium, for example, subsyndromal deliria may be particularly difﬁcult to detect for any screening tool.
The MMSE has some limitations that may have inﬂuenced the
ﬁndings. It has an over-reliance on verbal assessment at the expense
of non-dominant hemisphere skills and executive functioning, insensitivity to frontal executive dysfunction and visuospatial deﬁcits, superﬁcial assessment of memory and language and inability to provide
qualitative information of cognitive proﬁle [58]. Although, the MMSE
has high sensitivity and speciﬁcity with a good positive predictive
validity and negative predictive validity it is modestly effective in ruling
out dementia [29,39]. Scales for cognitive assessment can be inﬂuenced
by factors including age, educational status, affective changes and

ﬂuctuations in cognitive picture, compromising their accuracy. Unfortunately only two studies (see Table 1) examined here looked at younger
adults therefore the effect of age remains unaddressed. High interobserver agreement for the MMSE, the Delirium Symptom Inventory
and the CAM suggest that they may different but overlapping assessment of delirium.
Although the brief bedside tools for assessment of cognitive functions
have a role, it is important to keep in mind that they should not be used
to replace a full clinical appraisal to reach a diagnosis of delirium. Hence,
the MMSE can be used as an aid to ascertain the cognitive status to
monitor any improvement or deterioration to facilitate the process of
making and reviewing a clinical diagnosis and management for early
intervention for resolution of delirium.
We conclude that the MMSE should not be used as a case-ﬁnding
conﬁrmatory test of delirium as it would be accurate in one in four
to one in two cases, but it could be used as an initial screen to rule
out those who are unlikely to have delirium with approximately
93–97% accuracy.
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